Timolol maleate ophthalmic solution is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
The medication is a two-drug combination of emtricitabine and tenofovir disoproxil fumarate, both HIV-1 nucleoside analog reverse transcriptase inhibitors.
NACDS’ “Pharmacies. The face of neighborhood health care” campaign tells the story of pharmacies’ effectiveness in serving the American public during emergencies and every day.
This marks Hikma’s official entry into France, which has the second largest pharmaceutical market in Europe and a generic injectables hospital market of approximately $2 billion.
